Bevacizumab for newly diagnosed glioblastoma.
Mark R
MR
Gilbert
Erik P
EP
Sulman
Minesh P
MP
Mehta
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized